← Evidence map

ArticleClinical kidney journal2025

One tool, multiple gains: anti-CD38 therapy in antibody-mediated rejection.

Raphaël Etiève et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 41393858